Connor, Clark & Lunn Investment Management Ltd. Myovant Sciences Ltd. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$7.78 - $14.69 $437,523 - $826,121	-56,237 Reduced 40.08%	84,086 $1.05 Million
Q1 2022 May 12, 2022	SELL	$11.38 - $16.4 $533,084 - $768,241	-46,844 Reduced 25.03%	140,323 $1.87 Million
Q4 2021 Feb 10, 2022	SELL	$14.31 - $23.87 $357,020 - $595,532	-24,949 Reduced 11.76%	187,167 $2.91 Million
Q3 2021 Nov 12, 2021	SELL	$18.94 - $26.99 $516,001 - $735,315	-27,244 Reduced 11.38%	212,116 $4.76 Million
Q2 2021 Aug 12, 2021	BUY	$17.07 - $24.56 $228,908 - $329,349	13,410 Added 5.93%	239,360 $5.45 Million
Q1 2021 May 13, 2021	BUY	$20.46 - $25.18 $103,016 - $126,781	5,035 Added 2.28%	225,950 $4.65 Million
Q4 2020 Feb 16, 2021	SELL	$13.8 - $27.62 $226,471 - $453,271	-16,411 Reduced 6.91%	220,915 $6.1 Million
Q3 2020 Nov 12, 2020	SELL	$14.05 - $22.6 $1.64 Million - $2.63 Million	-116,381 Reduced 32.9%	237,326 $3.33 Million
Q2 2020 Aug 13, 2020	BUY	$7.34 - $20.84 $179,514 - $509,683	24,457 Added 7.43%	353,707 $7.29 Million
Q1 2020 May 13, 2020	BUY	$6.55 - $14.76 $910,705 - $2.05 Million	139,039 Added 73.1%	329,250 $2.49 Million
Q4 2019 Feb 12, 2020	BUY	$4.2 - $19.21 $798,886 - $3.65 Million	190,211 New	190,211 $2.95 Million

Others Institutions Holding MYOV

# of Institutions

Shares Held

61.3K

Call Options Held

Put Options Held

View Full List

About Myovant Sciences Ltd.

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

More about MYOV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account